From the very beginning, Biofarma Group has played an important role in the fight against the Covid-19 pandemic. In addition to the production of disinfectant, the group offered its many years of experience in medical production for the creation of a new diagnostic methodology.
The collaboration with the hospital in Udine thus gave rise to the saliva test: less invasive, but capable of identifying up to 12% more positive cases than traditional oropharyngeal tests.
Full details of the project can be found in this article in Il Sole24ore.
> Download pdf
